VTGN
VistaGen Therapeutics Inc
0.2336$
+1.3%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of VistaGen Therapeutics Inc (VTGN) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/10/2026 | Current report (8-K) | Vistagen Therapeutics, Inc. (VTGN): Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
| 08/14/2026 | Current report (8-K) | Vistagen Therapeutics, Inc. (VTGN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 08/06/2026 | Current report (8-K) | Vistagen Therapeutics, Inc. (VTGN): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/05/2026 | Current report (8-K) | Vistagen Therapeutics, Inc. (VTGN): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | View report ↗ |
| 07/31/2026 | Current report (8-K) | Vistagen Therapeutics, Inc. (VTGN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.